Imagindairy, an Israeli-based foodtech company developing sustainable and commercially viable animal-free dairy proteins, and Ginkgo Bioworks announced a new partnership. Together, Ginkgo and Imagindairy aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner. This collaboration will leverage Ginkgo Protein Expression Services and Imagindairy’s process development and scale-up expertise to accelerate the development of functional non-whey dairy proteins. This is a multi-year program, funded in part by a joint grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development Foundation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Largest borrow rate increases among liquid names
- ProteoNic Biosciences announces pact with Ginkgo Bioworks
- Ginkgo Bioworks, CDC, Xwell expand Traveler-based Genomic Surveillance program
- Cathie Wood’s ARK Investment bought 5.8M shares of Ginkgo Bioworks today
- Ginkgo Bioworks price target lowered to $3 from $7 at TD Cowen